Marine sponge microbe provides insights into evolution and virulence of the tubercle bacillus

Sacha J. Pidot,Stephan Klatt,Louis S. Ates,Wafa Frigui,Fadel Sayes,Laleh Majlessi,Hiroshi Izumi,Ian R. Monk,Jessica L. Porter,Vicki Bennett-Wood,Torsten Seemann,Ashley Otter,George Taiaroa,Gregory M. Cook,Nicholas West,Nicholas J. Tobias,John A. Fuerst,Michael D. Stutz,Marc Pellegrini,Malcolm McConville,Roland Brosch,Timothy P. Stinear
DOI: https://doi.org/10.1371/journal.ppat.1012440
IF: 7.464
2024-09-02
PLoS Pathogens
Abstract:Reconstructing the evolutionary origins of Mycobacterium tuberculosis , the causative agent of human tuberculosis, has helped identify bacterial factors that have led to the tubercle bacillus becoming such a formidable human pathogen. Here we report the discovery and detailed characterization of an exceedingly slow growing mycobacterium that is closely related to M . tuberculosis for which we have proposed the species name Mycobacterium spongiae sp. nov., (strain ID: FSD4b-SM). The bacterium was isolated from a marine sponge, taken from the waters of the Great Barrier Reef in Queensland, Australia. Comparative genomics revealed that, after the opportunistic human pathogen Mycobacterium decipiens , M . spongiae is the most closely related species to the M . tuberculosis complex reported to date, with 80% shared average nucleotide identity and extensive conservation of key M . tuberculosis virulence factors, including intact ESX secretion systems and associated effectors. Proteomic and lipidomic analyses showed that these conserved systems are functional in FSD4b-SM, but that it also produces cell wall lipids not previously reported in mycobacteria. We investigated the virulence potential of FSD4b-SM in mice and found that, while the bacteria persist in lungs for 56 days after intranasal infection, no overt pathology was detected. The similarities with M . tuberculosis , together with its lack of virulence, motivated us to investigate the potential of FSD4b-SM as a vaccine strain and as a genetic donor of the ESX-1 genetic locus to improve BCG immunogenicity. However, neither of these approaches resulted in superior protection against M . tuberculosis challenge compared to BCG vaccination alone. The discovery of M . spongiae adds to our understanding of the emergence of the M . tuberculosis complex and it will be another useful resource to refine our understanding of the factors that shaped the evolution and pathogenesis of M . tuberculosis . Tuberculosis, caused by Mycobacterium tuberculosis , is still one of the world's deadliest infectious diseases. However, the origins and rise of M . tuberculosis as a successful pathogen are not well understood. Here, we report the isolation and characterisation of a marine sponge-derived mycobacterium ( M . spongiae ) from the Great Barrier Reef that has striking genotypic similarity to M . tuberculosis , with 80% average nucleotide identity. We further show by proteomic and lipidomic analyses that M . spongiae shares virulence factors and unique cell wall lipids with the tubercle bacillus. In spite of these conserved genotypic and phenotypic features, M . spongiae was not virulent in a mouse model of infection, leading us to investigate its potential as a vaccine strain or genetic donor for enhancing the current BCG vaccine for tuberculosis. Our findings contribute to understanding the evolutionary origins of M . tuberculosis and provide further insights into its pathogenesis.
microbiology,virology,parasitology
What problem does this paper attempt to address?